Compass Therapeutics (NASDAQ:CMPX) Upgraded to Strong-Buy at Leerink Partnrs
Leerink Partnrs upgraded shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) from a hold rating to a strong-buy rating in a research note released on Tuesday morning,Zacks.com reports. Other equities research analysts have also issued research reports about the company. Jefferies Financial Group increased their price target on Compass Therapeutics from $7.00 to $8.00 and […]
Leerink Partnrs upgraded shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) from a hold rating to a strong-buy rating in a research note released on Tuesday morning,Zacks.com reports. Other equities research analysts have also issued research reports about the company. Jefferies Financial Group increased their price target on Compass Therapeutics from $7.00 to $8.00 and […]
